Pharmaceutical Raw Material Shortages Post-Hormuz

The 2026 Strait of Hormuz disruption highlighted the pharmaceutical industry's dependence on globally connected chemical supply chains. While much of the public attention focused on oil and energy markets, the disruption also affected the movement of pharmaceutical raw materials, healthcare packaging components, and medical technology supplies.

Many pharmaceutical manufacturers rely on internationally sourced chemicals, excipients, packaging polymers, and intermediates that transit through major global shipping routes. Delays in these supply chains can affect manufacturing schedules, inventory management, and procurement planning.

For pharmaceutical manufacturers, distributors, and procurement professionals, the Hormuz disruption reinforces the importance of building resilient sourcing strategies that reduce dependence on a single transportation corridor or supplier region.

Why Pharmaceutical Supply Chains Were Affected

Modern pharmaceutical manufacturing depends on a wide range of raw materials sourced from multiple countries.

These include:

• Active Pharmaceutical Ingredients (APIs)

• Pharmaceutical excipients

• Packaging materials

• Medical-grade polymers

• Specialty solvents

• Laboratory chemicals

When shipping routes experience disruption, delivery schedules can be affected even if manufacturing facilities continue operating normally.

Pharmaceutical manufacturers depend on essential raw materials such as Propylene Glycol (USP Grade), Polyethylene Glycol (PEG), Mannitol, Citric Acid, Sorbitol, Glycerin, and Isopropyl Alcohol (IPA) for medicine production and formulation. Any disruption to global shipping routes can affect the timely availability of these widely used pharmaceutical ingredients.

The Impact on Procurement

Supply chain disruptions create several operational challenges for procurement teams.

Potential impacts include:

• Longer supplier lead times

• Higher transportation costs

• Inventory shortages

• Delayed production schedules

• Increased sourcing complexity

• Greater supplier risk

Organizations with diversified supplier networks generally adapt more effectively to unexpected logistics disruptions.

Building a More Resilient Supply Chain

The Hormuz disruption has encouraged pharmaceutical companies to strengthen procurement strategies through improved risk management.

Key approaches include:

• Multi-source supplier qualification

• Regional supplier diversification

• Strategic safety stock planning

• Digital supply chain monitoring

• Long-term supplier partnerships

• Regular supply chain risk assessments

These measures help improve business continuity during future geopolitical or logistics disruptions.

Procurement Considerations

Pharmaceutical procurement professionals should regularly evaluate both suppliers and transportation networks.

Important considerations include:

• Supplier geographic diversity

• Regulatory compliance

• Inventory management

• Logistics flexibility

• Alternative shipping routes

• Supply chain visibility

A balanced sourcing strategy helps reduce exposure to disruptions affecting any single region or transportation corridor.

Looking Ahead

Global pharmaceutical supply chains are expected to remain highly interconnected, making resilience an increasingly important competitive advantage. The lessons learned from the Hormuz disruption are encouraging companies to diversify suppliers, strengthen logistics planning, and improve supply chain visibility.

For procurement teams, maintaining reliable supplier relationships while expanding sourcing flexibility will be essential for ensuring uninterrupted pharmaceutical production in an evolving global trade environment.

Key Takeaways

• The Hormuz disruption affected pharmaceutical raw material logistics beyond the energy sector.

• APIs, excipients, packaging materials, and specialty chemicals rely on global supply chains.

• Diversified sourcing improves resilience against transportation disruptions.

• Procurement teams should strengthen supplier and logistics risk management.

• Long-term supply chain resilience requires continuous planning and supplier diversification.